Russell Investments Group, Ltd. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$7,953
-29.5%
78
-37.1%
0.00%
Q1 2023$11,274
-95.2%
124
-98.0%
0.00%
Q4 2022$233,334
+80.9%
6,142
+19.3%
0.00%
Q3 2022$129,000
-88.4%
5,148
-87.8%
0.00%
-100.0%
Q4 2021$1,108,000
-73.3%
42,089
+2.1%
0.00%
-71.4%
Q3 2021$4,145,000
-17.0%
41,215
+16.7%
0.01%
-12.5%
Q2 2021$4,996,000
+453.9%
35,317
+510.3%
0.01%
+300.0%
Q2 2020$902,000
+311.9%
5,787
+280.0%
0.00%
+100.0%
Q1 2020$219,000
-79.3%
1,523
-70.6%
0.00%
-50.0%
Q4 2019$1,060,000
+430.0%
5,186
+107.7%
0.00%
Q3 2019$200,000
-21.3%
2,497
-68.8%
0.00%
Q2 2017$254,0008,0120.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders